Developing new biomarkers into commercially successful products requires expertise, time and money. At Trans-Hit Biomarkers we know the challenges you face in taking your newly discovered biomarker through validation and eventually to a commercialized product. Our expertise in helping biomarker scientists to advance their biomarkers to the market is widely recognized by many well-known TTOs and key industrial players in the biomarker domain.
- Guidance on priorities within your biomarker portfolio:
Trans-Hit Biomarkers will evaluate your biomarker programs, based on your existing experimental data, your IP, the market environment, and the regulatory requirements. This assessment will help you to decide on which technology your efforts and resources should be focused.
Biomarker Opportunity Listing: join numerous TTOs all over the world and list your biomarker out-licensing opportunities for free on our dedicated B4B-Hub for biomarkers.
Our B4B-Hub is an efficient channel to reach potential partners, with hundreds of diagnostic and pharmaceutical companies visiting on a regular basis. There is no cost, no hidden conditions and no obligation to use other Trans-Hit Biomarkers services. You keep full control (list, modify, or remove your biomarker listing) using the account management tool. It is easy to use: link your institution's web page directly to the Trans-Hit Biomarkers B4B-Hub.
- R&D tools to quickly generate a solid, reliable and valuable proof-of-concept for successful out-licensing of your biomarker technologies:
o Review and optimization of scientific and strategic development plans and IP strategy
o Validation of analytical methods